Company news
Kiniksa Pharmaceuticals International, plc news in 2019
Kiniksa Pharmaceuticals International, plc's news releases, calls and decks from 2019, newest first.
Kite and Kiniksa Pharmaceuticals Announce Clinical Collaboration Evaluating Investigational Combination of Yescarta® and Mavrilimumab in Relapsed or Refractory Large B-Cell Lymphoma
December 10, 2019
Kiniksa Pharmaceuticals to Present at 38th Annual J.P. Morgan Healthcare Conference
December 9, 2019
Kiniksa Pharmaceuticals to Present at the 2nd Annual Evercore ISI HealthCONx Conference
November 19, 2019
Kiniksa Announces Breakthrough Therapy Designation for Rilonacept for the Treatment of Recurrent Pericarditis
November 19, 2019
Kiniksa Presents Rilonacept Final Phase 2 Clinical Data at the American Heart Association Scientific Sessions 2019
November 15, 2019
Kiniksa Presents Preclinical Data on the Role of GM-CSF in GCA at the 2019 ACR/ARP Annual Meeting
November 11, 2019
Kiniksa Reports Third Quarter 2019 Financial Results and Highlights Recent Corporate and Pipeline Activity
October 27, 2019
Kiniksa Presents Preclinical Data Supporting KPL-716 Clinical Development at the 49th Annual Meeting of the European Society of Dermatological Research
September 18, 2019
Decks in 2019
- Investor Presentation (January 2019)
Investor deck · 47 slides · Jan 28, 2019